Taiyen Biotech Co Ltd Cash Flow Quality Index
Taiyen Biotech Co Ltd cash flow quality index. Taiyen Biotech Co Ltd (1737) has a Cash Flow Quality Index of 1.25x as of June 2026. Operating cash flow of NT$99.80 Million exceeds net income of NT$79.62 Million, indicating high earnings quality where cash backs reported profits. See 1737 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Taiyen Biotech Co Ltd (2003–2025)
Cash flow quality index of Taiyen Biotech Co Ltd from 2003 to 2025. Historical Cash Flow Quality Index for Taiyen Biotech Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Taiyen Biotech Co Ltd (1737) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Taiyen Biotech Co Ltd Cash Flow Quality Index by Year (2003–2025)
Taiyen Biotech Co Ltd cash flow quality index by year from 2003 to 2025. Year-by-year earnings quality comparison for Taiyen Biotech Co Ltd. For the full cash flow conversion analysis, see Taiyen Biotech Co Ltd (1737) cash flow conversion.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.18x | NT$473.77 Million | NT$399.87 Million | ▼ -33.3% |
| 2024 | 1.78x | NT$660.12 Million | NT$371.52 Million | ▲ +17.4% |
| 2023 | 1.51x | NT$454.54 Million | NT$300.39 Million | ▲ +11.2% |
| 2022 | 1.36x | NT$580.69 Million | NT$426.70 Million | ▲ +15.6% |
| 2021 | 1.18x | NT$600.08 Million | NT$509.92 Million | ▲ +60.9% |
| 2020 | 0.73x | NT$339.36 Million | NT$464.04 Million | ▼ -5.3% |
| 2019 | 0.77x | NT$330.81 Million | NT$428.55 Million | ▼ -8.8% |
| 2018 | 0.85x | NT$449.83 Million | NT$531.59 Million | ▼ -40.6% |
| 2017 | 1.43x | NT$607.87 Million | NT$426.48 Million | ▲ +4.1% |
| 2016 | 1.37x | NT$568.06 Million | NT$414.82 Million | ▲ +13.9% |
| 2015 | 1.20x | NT$383.93 Million | NT$319.34 Million | ▼ -20.4% |
| 2014 | 1.51x | NT$371.06 Million | NT$245.76 Million | ▲ +6.6% |
| 2013 | 1.42x | NT$203.21 Million | NT$143.54 Million | ▼ -28.4% |
| 2012 | 1.98x | NT$154.46 Million | NT$78.11 Million | ▲ +56.0% |
| 2011 | 1.27x | NT$246.09 Million | NT$194.07 Million | ▼ -23.5% |
| 2010 | 1.66x | NT$300.89 Million | NT$181.41 Million | ▼ -2.8% |
| 2009 | 1.71x | NT$358.02 Million | NT$209.77 Million | ▼ -75.1% |
| 2007 | 6.86x | NT$322.49 Million | NT$46.99 Million | ▲ +407.6% |
| 2006 | 1.35x | NT$462.88 Million | NT$342.33 Million | ▼ -96.4% |
| 2005 | 37.26x | NT$575.91 Million | NT$15.46 Million | ▲ +1254.2% |
| 2004 | 2.75x | NT$2.84 Billion | NT$1.03 Billion | ▼ -22.7% |
| 2003 | 3.56x | NT$3.42 Billion | NT$960.78 Million | — |